登录 查看组织和合同定价。
选择尺寸
变更视图
关于此项目
经验公式(希尔记法):
C26H40O5
化学文摘社编号:
分子量:
432.59
NACRES:
NA.77
PubChem Substance ID:
UNSPSC Code:
12352200
MDL number:
Quality Level
assay
≥98% (HPLC)
form
oil
color
colorless to yellow
solubility
DMSO: freely soluble, methanol: soluble
originator
Johnson & Johnson
shipped in
wet ice
storage temp.
−20°C
SMILES string
CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1CC[C@@H](O)CCc2ccccc2
InChI
1S/C26H40O5/c1-19(2)31-26(30)13-9-4-3-8-12-22-23(25(29)18-24(22)28)17-16-21(27)15-14-20-10-6-5-7-11-20/h3,5-8,10-11,19,21-25,27-29H,4,9,12-18H2,1-2H3/b8-3-/t21-,22+,23+,24-,25+/m0/s1
InChI key
GGXICVAJURFBLW-CEYXHVGTSA-N
Gene Information
human ... PTGFR(5737)
Application
拉坦前列素已被用于:
- 制备包含姜黄素纳米颗粒(CUR-NP)的热敏水凝胶,以确定其在氧化应激下对人小梁网(TM)细胞的治疗作用。
- 作为酯类前药用于研究其对小鼠鼠眼表面的作用
- 制备热敏水凝胶用于研究其对控制高眼压症的作用。
Biochem/physiol Actions
拉坦前列素是一种强效、选择性前列腺素F2 α类似物受体激动剂。它在角膜中被酯酶水解为拉坦前列素酸的生物活性形式。拉坦前列素在降低眼内压(IOP)方面起一定作用,因此它具有治疗青光眼的疗效。
Features and Benefits
该化合物由 Johnson & Johnson 开发。如需浏览其他制药公司开发的化合物和批准的药物/候选药物列表,请点击此处。
Still not finding the right product?
Explore all of our products under 拉坦前列素
signalword
Warning
hcodes
Hazard Classifications
Repr. 2
存储类别
10 - Combustible liquids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Faceshields, Gloves, type N95 (US)
商品
Discover Bioactive Small Molecules for Lipid Signaling Research
0.005% Preservative-free latanoprost induces dry eye-like ocular surface damage via promotion of inflammation in mice
Yang Y, et al.
Investigative Ophthalmology & Visual Science, 59(8), 3375-3384 (2018)
Latanoprost ophthalmic solution in the treatment of open angle glaucoma or raised intraocular pressure: a review
Russo A, et al.
Clinical Ophthalmology (Auckland, N.Z.), 2(4), 897-897 (2008)
Latanoprost could exacerbate the progression of presbyopia
Ayaki M, et al.
PLoS ONE, 14(1) (2019)
全球贸易项目编号
| 货号 | GTIN |
|---|---|
| L1167-1MG | 04061826675618 |
| L1167-5MG | 04061832785578 |
